Evolent Health (EVH) Tops Q1 EPS by 13c; raises guidance

Evolent Health (NYSE: EVH) reported Q1 EPS of $0.34, $0.13 better than the analyst estimate of $0.21. Revenue for the quarter came in at $639.65 million versus the consensus estimate of $600.82 million.

GUIDANCE:

Evolent Health sees Q2 2024 revenue of $625-645 million, versus the consensus of $606.6 million.

Evolent Health sees FY2024 revenue of $2.53-2.6 billion, versus the consensus of $2.467 billion.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Carnival shares drop despite earnings beat on weak guidance